Breast cancer diagnosed during pregnancy is associated with enrichment of non-silent mutations, mismatch repair deficiency signature and mucin mutations

dc.contributor.authorNguyen, Bastien D.
dc.contributor.authorVenet, David
dc.contributor.authorAzim, Hatem A.
dc.contributor.authorBrown, David N.
dc.contributor.authorDesmedt, Christine
dc.contributor.authorLambertini, Matteo Md Phd
dc.contributor.authorMajjaj, Samira
dc.contributor.authorPruneri, Giancarlo
dc.contributor.authorPeccatori, Fedro Alessandro
dc.contributor.authorPiccart-Gebhart, Martine J.
dc.contributor.authorRothé, Françoise
dc.contributor.authorSotiriou, Christos
dc.contributor.departmentInternal Medicine
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:53:08Z
dc.date.available2025-01-24T11:53:08Z
dc.date.issued2018
dc.description.abstractBreast cancer diagnosed during pregnancy (BCP) is a rare and highly challenging disease. To investigate the impact of pregnancy on the biology of breast cancer, we conducted a comparative analysis of a cohort of BCP patients and non-pregnant control patients by integrating gene expression, copy number alterations and whole genome sequencing data. We showed that BCP exhibit unique molecular characteristics including an enrichment of non-silent mutations, a higher frequency of mutations in mucin gene family and an enrichment of mismatch repair deficiency mutational signature. This provides important insights into the biology of BCP and suggests that these features may be implicated in promoting tumor progression during pregnancy. In addition, it provides an unprecedented resource for further understanding the biology of breast cancer in young women and how pregnancy could modulate tumor biology. © 2018, The Author(s).
dc.identifier.doihttps://doi.org/10.1038/s41523-018-0077-3
dc.identifier.eid2-s2.0-85056724237
dc.identifier.urihttp://hdl.handle.net/10938/31094
dc.language.isoen
dc.publisherNature Publishing Group
dc.relation.ispartofnpj Breast Cancer
dc.sourceScopus
dc.subjectMucin
dc.subjectArticle
dc.subjectBreast cancer
dc.subjectCancer diagnosis
dc.subjectCase control study
dc.subjectCohort analysis
dc.subjectComparative study
dc.subjectControlled study
dc.subjectCopy number variation
dc.subjectDisease association
dc.subjectFemale
dc.subjectGene expression
dc.subjectGene frequency
dc.subjectGene mutation
dc.subjectGenetic association
dc.subjectHuman
dc.subjectHuman tissue
dc.subjectMajor clinical study
dc.subjectMismatch repair
dc.subjectMucin gene
dc.subjectMutation rate
dc.subjectNon silent mutation
dc.subjectPregnancy
dc.subjectPriority journal
dc.subjectRetrospective study
dc.subjectTumor growth
dc.subjectTumor promotion
dc.subjectWhole genome sequencing
dc.titleBreast cancer diagnosed during pregnancy is associated with enrichment of non-silent mutations, mismatch repair deficiency signature and mucin mutations
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2018-7823.pdf
Size:
1.18 MB
Format:
Adobe Portable Document Format